Although further studies are required to determine the therapeutic effect of IGF-1 in protecting RGC viability and neurite outgrowth in vivo, our results present IGF-1 as a novel therapeutic strategy for reducing the vision loss and blindness that result from hypoxia-induced retinal cell loss. Here, IGF1 is linked to Blindness.